Home » Authors » Anette Breindl

Articles by Anette Breindl

Study Links Mitochondrial Damage to A-beta Toxicity

April 6, 2009

By Anette Breindl

Second Trash Disposal System may be Useful in Huntington's

April 3, 2009

By Anette Breindl

High-Dose EPO is No Use, may be Harmful, After Heart Attack

March 31, 2009

By Anette Breindl

New Route for Toxic Asset's Exit Strategy is Discovered

March 27, 2009

By Anette Breindl

Local COX-2 Inhibition May Give Benefits with Less Risk

March 25, 2009

By Anette Breindl

'Endogenous Lithium' Found to Play Role in Schizophrenia

March 23, 2009

By Anette Breindl

Double-Duty Herceptin Variant Challenges Antibody Dogma

March 20, 2009

By Anette Breindl

Study probes link between Alzheimer's and brain injury

March 19, 2009

By Anette Breindl

Study Probes Link Between Alzheimer's and Brain Injury

March 17, 2009

By Anette Breindl

Paper Shows Bias in Profiling Methods, but also a Solution

March 16, 2009

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...